Home Cart 0 Sign in  
X

[ CAS No. 588703-29-1 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
3d Animation Molecule Structure of 588703-29-1
Chemical Structure| 588703-29-1
Chemical Structure| 588703-29-1
Structure of 588703-29-1 * Storage: {[proInfo.prStorage]}
Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Quality Control of [ 588703-29-1 ]

Related Doc. of [ 588703-29-1 ]

Alternatived Products of [ 588703-29-1 ]

Product Details of [ 588703-29-1 ]

CAS No. :588703-29-1 MDL No. :MFCD11977827
Formula : C10H8O3 Boiling Point : -
Linear Structure Formula :- InChI Key :GVDHNZDNWGZFLB-UHFFFAOYSA-N
M.W : 176.17 Pubchem ID :22481705
Synonyms :

Calculated chemistry of [ 588703-29-1 ]

Physicochemical Properties

Num. heavy atoms : 13
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.1
Num. rotatable bonds : 2
Num. H-bond acceptors : 3.0
Num. H-bond donors : 0.0
Molar Refractivity : 47.49
TPSA : 39.44 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.83 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.25
Log Po/w (XLOGP3) : 2.18
Log Po/w (WLOGP) : 2.22
Log Po/w (MLOGP) : 1.38
Log Po/w (SILICOS-IT) : 2.23
Consensus Log Po/w : 2.05

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -2.69
Solubility : 0.363 mg/ml ; 0.00206 mol/l
Class : Soluble
Log S (Ali) : -2.64
Solubility : 0.402 mg/ml ; 0.00228 mol/l
Class : Soluble
Log S (SILICOS-IT) : -3.36
Solubility : 0.0769 mg/ml ; 0.000437 mol/l
Class : Soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 2.23

Safety of [ 588703-29-1 ]

Signal Word:Warning Class:N/A
Precautionary Statements:P280-P305+P351+P338 UN#:N/A
Hazard Statements:H302 Packing Group:N/A
GHS Pictogram:

Application In Synthesis of [ 588703-29-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 588703-29-1 ]
  • Downstream synthetic route of [ 588703-29-1 ]

[ 588703-29-1 ] Synthesis Path-Upstream   1~13

  • 1
  • [ 67-56-1 ]
  • [ 201230-82-2 ]
  • [ 227752-25-2 ]
  • [ 588703-29-1 ]
YieldReaction ConditionsOperation in experiment
91% With 1,3-bis-(diphenylphosphino)propane; palladium diacetate; triethylamine In N,N-dimethyl-formamide at 70℃; for 6 h; Autoclave [00132] The benzofuranyl carbonyl moiety was prepared by protecting the hydroxyl groupof compound 13 by reacting with tert-butyldimethylsilyl chloride (1.0 equivalents) andtriethylamine (TEA, 1.1 equivalents) in acetone, to give compound 14 in 79percent yield. A solutionof compound 14 in methanol was then treated with sodium borohydride (1.0 equivalent) at roomtemperature overnight. The reaction was quenched with an addition of acetone, stirred at roomtemperature for a further 2.5 hours, aqueous HC1 (4N) was added with the temperature controlledto below 28 °C, tetrahydrofuran (THF) was added, and the solution stirred overnight under argonand in the absence of light. The product, compound 15, was isolated quantitatively by extractioninto methylene chloride, concentrated at low heat, and used without further purification. Thetriflate ester, compound 16, was produced in 69percent yield from compound 15 by reacting it with Nphenyl-bis(trifluoromethanesulfonimide) (1.0 equivalent) in methylene chloride for 72 hours.Compound 16 in a mixture of DMF, methanol, and triethylamine, was added to a preparedsolution of palladium acetate, 1,3-Bis(diphenylphosphino)propane (dppp), DMF and methanol inan autoclave. Carbon monoxide was charged into the autoclave to a pressure of 8 bar, and the reaction mixture was heated at 70 °C for 6 hours. After workup, compound 17 was isolated in 91percent yield. Lithium hydroxide (4 equivalents) in methanol and water was used to hydrolyze the ester and permit the isolation of compound 18’ in 97percent yield.
80% With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 70℃; for 24 h; Step d: Methyl benzofuran-6-carboxylate; A mixture of benzofuran-6-yl trifluoromethanesulfonate (16.2 g, 61 mmol), 1,3- bis(diphenyl phosphino)propane (1.4 g, 3.3 mmol) and Pd(OAc)2 (756 mg, 3.3 mmol) in DIEA (16.2 g, 124 mmol), MeOH (153 mL) and DMF (153 mL) was stirred at 70 °C under atmosphere of CO for 24 h. The reaction mixture was diluted with water, and extracted with ethyl acetate. The combined organic layer was then washed with brine and dried over Na2SO4, filtered and concentrated to afford a crude mixture that was purified by column chromatography on silica gel (5-10percent ethyl acetate in petroleum ether) to yield methyl benzofuran-6-carboxylate (8.5 g, 80 percent yield). 1H NMR (300 MHz, CDCl3) δ: 8.21(s, IH), 7.96 (dd, J =8.1, 1.5, IH), 7.76 (d, J= 2.1, IH), 7.63 (d, J= 8.1, IH), 6.83-6.82 (m, IH), 3.95 (s, IH).
65% With N-ethyl-N,N-diisopropylamine In DMF (N,N-dimethyl-formamide) at 65℃; A mixture of 50 mmol of compound 1.9, 2.5 mmol of dppp (diphenylphosphine-1, 3-propane) and 2.5 mmol of Pd (OAc) 2 in 100 mmol of DIEA, 125 mL of dry DMF, and 125 mL of anhydrous MeOH was stirred at 65°C under an atmosphere of CO overnight. The solvent was removed and the residue was purified by column chromatography to give compound 1.10 in 65percent yield. IH NMR (400 MHz, CD13) : 8 8.23 (s, 1H), 7.99 (d, J= 8.3 Hz, 1H), 7.78 (s, 1H), 7.65 (d, J= 8. 3 Hz, 1H), 6. 85 (s, 1H), 3.97 (s, 3H) ppm; ESI-MS (mlz) : (M+1) 177.10.
Reference: [1] ACS Medicinal Chemistry Letters, 2012, vol. 3, # 3, p. 203 - 206
[2] Patent: WO2014/18748, 2014, A1, . Location in patent: Paragraph 00131; 00132; 00133; 00134; 00135
[3] Patent: WO2008/141119, 2008, A2, . Location in patent: Page/Page column 77-78
[4] Patent: WO2005/44817, 2005, A1, . Location in patent: Page/Page column 80
  • 2
  • [ 616-38-6 ]
  • [ 128851-73-0 ]
  • [ 588703-29-1 ]
YieldReaction ConditionsOperation in experiment
91.2%
Stage #1: With n-butyllithium In tetrahydrofuran at -65 - -60℃; for 4 h;
Stage #2: at -65℃; for 5 h;
5.28 g (0.0268 mol) of 6-bromobenzofuran was added to a 250 mL three-necked flask, 80 ml of dry tetrahydrofuran was added, stirred and dissolved, then placed in a freezer to cool to -65 ° C, n-butyllithium was added dropwise (2M) 14.74mL, maintained the temperature at -60 °C during the addition process, and dropwise addition completion in 1h. After the reaction was continued for 3 hours, 2.89 g (0.0321 mol) of dimethyl carbonate was added dropwise under this reaction conditions, and the dropwise addition was completed in 1 hour, and the reaction temperature was controlled to -65 ° C. After the reaction for 4 hours, the reaction was completed. and the reaction was quenched by dropwise addition of a saturated ammonium chloride solution under a low temperature condition. The reaction was quenched by dropwise addition of a saturated ammonium chloride solution under a low temperature condition, after the solvent was evaporated under reduced pressure, residue was stirred by adding 100ml of water and 100 ml of dichloromethane , and then the layers were separated. The organic layer was washed twice with saturated brine, 100 mL each time, and the dichloromethane layer was dried over anhydrous magnesium sulfate and filtered, dichloromethane was evaporated under reduced pressure to obtain 6-methyl formate benzofuran 4.3g. yield 91.2percent and HPLC purity 97.2percent.
Reference: [1] Patent: CN108129430, 2018, A, . Location in patent: Paragraph 0008; 0016; 0018; 0020
  • 3
  • [ 478169-68-5 ]
  • [ 67-56-1 ]
  • [ 588703-29-1 ]
YieldReaction ConditionsOperation in experiment
70%
Stage #1: With copper(l) iodide In methanol at 75℃; for 3 h;
Stage #2: With pyrographite In methanol at 20 - 95℃;
Stage #3: With sodium hydroxide In ethanol at 20℃;
Methyl 3-hydroxy-4-[(trimethylsilyl)ethynyl]benzoate (4.15 g, 16.7 mmol) is dissolved in MeOH (45 ml) and treated with DIA (2.34 ml, 16.7 mmol). Copper iodide (159 mg, 0.84 mmol) is added portion-wise and the reaction is heated at 75° C. for 3 h. DARCO (2 g) is added and the reaction is stirred at 95° C. for an additional 2 h, then overnight at RT. The reaction is filtered, concentrated to a brown oil and the crude material is chromatographed over 300 g slurry-packed silica gel, eluting with 10percent EtOAc/hexane. The appropriate fractions are collected and concentrated to afford 2.05 g (70percent) of methyl 1-benzofuran-6-carboxylate as an orange crystalline solid. 1H NMR (400 MHz, CDCl3) δ3.97, 6.84, 7.65, 7.78, 7.98, 8.22 ppm.
Reference: [1] Patent: US2003/232853, 2003, A1, . Location in patent: Page 45
  • 4
  • [ 478169-68-5 ]
  • [ 588703-29-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
  • 5
  • [ 13196-11-7 ]
  • [ 588703-29-1 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2012, vol. 3, # 3, p. 203 - 206
[2] Patent: WO2014/18748, 2014, A1,
[3] Patent: WO2008/141119, 2008, A2,
  • 6
  • [ 6272-26-0 ]
  • [ 588703-29-1 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2012, vol. 3, # 3, p. 203 - 206
[2] Patent: WO2014/18748, 2014, A1,
[3] Patent: WO2008/141119, 2008, A2,
  • 7
  • [ 299912-77-9 ]
  • [ 588703-29-1 ]
Reference: [1] ACS Medicinal Chemistry Letters, 2012, vol. 3, # 3, p. 203 - 206
[2] Patent: WO2014/18748, 2014, A1,
[3] Patent: WO2008/141119, 2008, A2,
  • 8
  • [ 166599-86-6 ]
  • [ 588703-29-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 16, p. 3094 - 3105
  • 9
  • [ 157942-12-6 ]
  • [ 588703-29-1 ]
Reference: [1] Journal of Medicinal Chemistry, 2006, vol. 49, # 14, p. 4425 - 4436
  • 10
  • [ 103204-81-5 ]
  • [ 588703-29-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 16, p. 3094 - 3105
  • 11
  • [ 79250-46-7 ]
  • [ 588703-29-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 16, p. 3094 - 3105
  • 12
  • [ 79950-41-7 ]
  • [ 588703-29-1 ]
Reference: [1] Journal of Medicinal Chemistry, 1995, vol. 38, # 16, p. 3094 - 3105
  • 13
  • [ 588703-29-1 ]
  • [ 1083168-69-7 ]
Reference: [1] Patent: WO2008/141119, 2008, A2,
Same Skeleton Products
Historical Records

Related Functional Groups of
[ 588703-29-1 ]

Esters

Chemical Structure| 78303-09-0

[ 78303-09-0 ]

Methyl 3-(p-tolyloxy)benzoate

Similarity: 0.92

Chemical Structure| 60677-14-7

[ 60677-14-7 ]

Ethyl 3-phenoxybenzoate

Similarity: 0.90

Chemical Structure| 74733-24-7

[ 74733-24-7 ]

Methyl 4-formyl-3-methoxybenzoate

Similarity: 0.90

Chemical Structure| 5368-81-0

[ 5368-81-0 ]

Methyl 3-methoxybenzoate

Similarity: 0.90

Chemical Structure| 71590-08-4

[ 71590-08-4 ]

3-Methoxy-5-(methoxycarbonyl)benzoic acid

Similarity: 0.90

Related Parent Nucleus of
[ 588703-29-1 ]

Benzofurans

Chemical Structure| 10035-16-2

[ 10035-16-2 ]

Benzofuran-5-carbaldehyde

Similarity: 0.90

Chemical Structure| 90484-22-3

[ 90484-22-3 ]

Benzofuran-7-carboxylic acid

Similarity: 0.89

Chemical Structure| 57830-14-5

[ 57830-14-5 ]

5-Phenoxyisobenzofuran-1(3H)-one

Similarity: 0.89

Chemical Structure| 90721-27-0

[ 90721-27-0 ]

Benzofuran-5-carboxylic acid

Similarity: 0.88

Chemical Structure| 77095-51-3

[ 77095-51-3 ]

Benzofuran-6-carboxylic acid

Similarity: 0.88